Young Wie-Yen, Zhao Lidong, Qian Yaping, Wang Qiuju, Li Ning, Greinwald John H, Guan Min-Xin
Institute of Otolaryngology, Chinese PLA General Hospital, Beijing, China.
Biochem Biophys Res Commun. 2005 Mar 25;328(4):1244-51. doi: 10.1016/j.bbrc.2005.01.085.
Mutations in mitochondrial DNA (mtDNA) have been found to be associated with sensorineural hearing loss. We report here the clinical, genetic, and molecular characterization of four Chinese pedigrees with aminoglycoside-induced and nonsyndromic hearing impairment. Clinical evaluation revealed the variable phenotype of hearing impairment including audiometric configuration in these subjects, although these subjects share some common features: bilateral and sensorineural hearing impairment. Strikingly, these Chinese pedigrees exhibited extremely low penetrance of hearing loss (5.2%, 4.8%, 4.2%, and 13.3%, respectively, and with an average 8% penetrance). In particular, four of all five affected matrilineal relatives of these pedigrees had aminoglycoside-induced hearing loss. Sequence analysis of the complete mitochondrial genomes in these pedigrees showed the distinct sets of mtDNA polymorphism, in addition to the identical homoplasmic A1555G mutation, associated with hearing impairment in many families from different genetic backgrounds. The fact that mtDNA of those pedigrees belonged to different haplogroups R9a, N9a, D4a, and D4 suggested that the A1555G mutation occurred sporadically and multiplied through evolution of the mtDNA in China. However, there was the absence of functionally significant mutations in tRNA and rRNAs or secondary LHON mutations in these Chinese families. These data imply that the nuclear background or/and mitochondrial haplotype may not play a significant role in the phenotypic expression of the A1555G mutation in these Chinese pedigrees. However, aminoglycoside appears to be a major modifier factor for the phenotypic manifestation of the A1555G mutation in these Chinese families.
线粒体DNA(mtDNA)突变已被发现与感音神经性听力损失有关。我们在此报告四个中国家系的临床、遗传和分子特征,这些家系患有氨基糖苷类药物诱发的非综合征性听力障碍。临床评估显示,这些受试者的听力障碍表型各异,包括听力图形态,尽管他们有一些共同特征:双侧感音神经性听力障碍。引人注目的是,这些中国家系的听力损失外显率极低(分别为5.2%、4.8%、4.2%和13.3%,平均外显率为8%)。特别是,这些家系中所有五名受影响的母系亲属中有四名患有氨基糖苷类药物诱发的听力损失。对这些家系的完整线粒体基因组进行序列分析发现,除了相同的纯合A1555G突变外,还有不同的mtDNA多态性组合,这一突变在来自不同遗传背景的许多家族中都与听力障碍有关。这些家系的mtDNA属于不同的单倍群R9a、N9a、D4a和D4,这一事实表明A1555G突变是在中国通过mtDNA的进化偶然发生并扩散的。然而,这些中国家系的tRNA和rRNA中没有功能上显著的突变,也没有继发性Leber遗传性视神经病变(LHON)突变。这些数据表明,核背景或/和线粒体单倍型可能在这些中国家系中A1555G突变的表型表达中不起重要作用。然而,氨基糖苷类药物似乎是这些中国家系中A1555G突变表型表现的主要修饰因子。